Inequity in adherence to empagliflozin and dulaglutide for type 2 diabetes in Aotearoa New Zealand. Mustafa S, Mayo C, Paul R, Rodrigues M, et al. Diabetes Obes Metab 2025 Jun 24. doi: 10.1111/dom.16558.

Read + Share

Amedeo Smart

Independent Medical Education

Mustafa S, Mayo C, Paul R, Rodrigues M, et al. Inequity in adherence to empagliflozin and dulaglutide for type 2 diabetes in Aotearoa New Zealand. Diabetes Obes Metab 2025 Jun 24. doi: 10.1111/dom.16558.
PMID: 40555685